Expression profiles of Th17 pathway related genes in human systemic lupus erythematosus

Molecular Biology Reports

Volumn 40, Issue 1, 2013, Pages 391-399

  Pan, Hai Feng ^a   Leng, Rui Xue ^a   Feng, Chen Chen ^a   Li, Xiang Pei ^b   Chen, Gui Mei ^a   Li, Bao Zhu ^a   Xu, Wang Dong ^a   Zheng, Song Guo ^c   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cytokine; Systemic lupus erythematosus; Th17

Indexed keywords

CD28 ANTIGEN; CD40 LIGAND; CXCL1 CHEMOKINE; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 5; INTERLEUKIN 8; JANUS KINASE 2; MESSENGER RNA; PROTEIN ISG20; PROTEIN S1PR1; RETINOID RELATED ORPHAN RECEPTOR GAMMA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; LEUKOCYTE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; UNINDEXED SEQUENCE;

ADULT; AUTOIMMUNITY; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; TH17 CELLS; YOUNG ADULT;

EID: 84871326281     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2073-2     Document Type: Article

References (48)

1. Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358:929-939
2. Goodnow CC, Sprent J, de St Groth BF et al (2005) Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435:590-597
3. Shlomchik MJ, Craft JE, Mamula MJ (2001) From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 1:147-153
4. Tsokos GC, Mitchell JP, Juang Y-T (2003) T cell abnormalities in human and mouse lupus: intrinsic and extrinsic. Curr Opin Rheumatol 15:542-547
5. Dardalhon V, Korn T, Kuchroo VK et al (2008) Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun 31:252-256
6. Nalbandian A, Crispín JC, Tsokos GC (2009) Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 157:209-215
7. Kurasawa K, Hirose K, Sano H et al (2000) Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum 43:2455-2463
8. Wong CK, Ho CY, Li EK et al (2000) Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9:589-593
9. Wong CK, Lit LC, Tam LS et al (2008) Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 127:385-393
10. Zhao XF, Pan HF, Yuan H et al (2010) Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep 37:81-85
11. Kwan BC, Tam LS, Lai KB et al (2009) The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus. Rheumatology (Oxford) 48:1491-1497
12. Crispín JC, Oukka M, Bayliss G et al (2008) Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 181:8761-8766
13. Wang Y, Ito S, Chino Y et al (2009) Laser microdissection-based analysis of cytokine balance in the kidneys of patients with lupus nephritis. Clin Exp Immunol 159:1-10
14. Kang HK, Liu M, Datta SK et al (2007) Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J Immunol 178:7849-7858
15. Wu HY, Quintana FJ, Weiner HL (2008) Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+CD25-LAP+ regulatory T cell and is associated with down-regulation of IL-17+CD4+ICOS+CXCR5+ follicular helper T cells. J Immunol 181:6038-6050
16. Pan HF, Ye DQ, Li XP (2008) Type 17 T-helper cells might be a promising therapeutic target for systemic lupus erythematosus. Nat Clin Pract Rheumatol 4:352-353
17. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
18. Pan HF, Zhao XF, Yuan H et al (2009) Decreased serum IL-22 levels in patients with systemic lupus erythematosus. Clin Chim Acta 401:179-180
19. Cheng F, Guo Z, Xu H et al (2009) Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 68:604-606
20. Furuse S, Fujii H, Kaburagi Y et al (2003) Serum concentrations of the CXC chemokines interleukin 8 and growth-regulated oncogene-alpha are elevated in patients with systemic sclerosis. J Rheumatol 30:1524-1528
21. van de Stolpe A, van der Saag PT (1996) Intercellular adhesion molecule-1. J Mol Med 74:13-33
22. Kim K, Brown EE, Choi CB et al (2012) Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries. Ann Rheum Dis. doi: 10.1136/annrheumdis-2011-201100
23. López P, Gutiérrez C, Suárez A (2010) IL-10 and TNFalpha genotypes in SLE. J Biomed Biotechnol 2010:838390
24. Elwakkad AS, Said RN, Muhammad SI et al (2007) Role for leptin and prolactin in human juvenile rheumatic diseases. Pak J Biol Sci 10:1984-1989
25. Holcombe RF, Baethge BA, Wolf RE et al (1994) Correlation of serum interleukin-8 and cell surface lysosome-associated membrane protein expression with clinical disease activity in systemic lupus erythematosus. Lupus 3:97-102
26. Hrycek E, Franek A, Błaszczak E et al (2012) Serum levels of selected chemokines in systemic lupus erythematosus patients. Rheumatol Int. doi: 10.1007/s00296-012-2393-5
27. Rovin BH, Lu L, Zhang X (2002) A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis. Kidney Int 62:261-265
28. Horio T, Murai M, Inoue T et al (2004) Crystal structure of human ISG20, an interferon-induced antiviral ribonuclease. FEBS Lett 577:111-116
29. Ishii T, Onda H, Tanigawa A et al (2005) Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients. DNA Res 12:429-439
30. Lu LD, Stump KL, Wallace NH et al (2011) Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2. J Immunol 187:3840-3853
31. Wong CK, Lit LCW, Tam LS et al (2005) Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology 44:989-994
32. Hebbar M, Jeannin P, Magistrelli G et al (2004) Detection of circulating soluble CD28 in patients with lupus erythematosus, primary Sjögren syndrome and systemic sclerosis. Clin Exp Immunol 136:388-392
33. Brambila-Tapia AJ, Gámez-Nava JI, Salazar-Páramo M et al (2011) Increased CD28 serum levels are not associated with specific clinical activity in systemic lupus erythematosus. Rheumatol Int 31:1321-1324
34. Brambila-Tapia AJ, Dávalos-Rodríguez IP, Gámez-Nava JI et al (2011) CD28 proximal promoter polymorphisms in systemic lupus erythematosus susceptibility. Rheumatol Int. doi: 10.1007/s00296-011-1942-7
35. Lu Q, Wu A, Tesmer L et al (2007) Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 179:6352-6358
36. Zhou Y, Yuan J, Pan Y et al (2009) T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin Immunol 132:362-370
37. Hikami K, Kawasaki A, Ito I et al (2011) Association of a functional polymorphism in the 3′-untranslated region of SPI1 with systemic lupus erythematosus. Arthritis Rheum 63:755-763
38. Wu B, Jin M, Zhang Y et al (2011) Evolution of the IL17 receptor family in chordates: a new subfamily IL17REL. Immunogenetics 63:835-845
39. Puwipirom H, Hirankarn N, Sodsai P et al (2010) Increased interleukin-23 receptor(+) T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Arthritis Res Ther 12:R215
40. Parham C, Chirica M, Timans J et al (2002) A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol 168:5699-5708
41. Safrany E, Hobor R, Jakab L et al (2010) Interleukin-23 receptor gene variants in Hungarian systemic lupus erythematosus patients. Inflamm Res 59:159-164
42. Kim HS, Kim I, Kim JO et al (2009) No association between interleukin 23 receptor gene polymorphisms and systemic lupus erythematosus. Rheumatol Int 30:33-38
43. Sánchez E, Rueda B, Callejas JL et al (2007) Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus. Tissue Antigens 70:233-237
44. Unutmaz D (2009) RORC2: the master of human Th17 cell programming. Eur J Immunol 39:1452-1455
45. Lohr J, Knoechel B, Wang JJ et al (2006) Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 203:2785-2791
46. Koenen HJ, Smeets RL, Vink PM et al (2008) Human CD25 high Foxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112:2340-2352
47. Beriou G, Costantino CM, Ashley CW et al (2009) IL-17 producing human peripheral regulatory T cells retain suppressive function. Blood 113:4240-4249
48. Zhou X, Kong N, Wang J et al (2010) Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J Immunol 185:2675-2679